Dr.Manikanda Arunachalam is a multi disciplinary professional with expertise in Venture capital and private equity with sectoral interest in Medical Devices, genomics, Digital Health and Healthcare IOT
Mani serves as a board of Director in The KEF company, a multi million dollar private investment firm in Dubai International Financial center (DIFC). At KEF company Mani oversees the Healthcare investment portfolio and is a key strategist in managing the healthcare investments.
Mani Served as an Operating Partner in Capricorn Healthcare and Special opportunities (CHSO) Fund. CHSO is a health care middle market growth equity fund in Palo Alto.
Earlier Mani served as a board of director in Motherhood India, a chain of boutique mother and delivery care hospital, where he was responsible for capital raising through private equity placement and corporate strategy and planning. TPG acquired significant stake of Motherhood in 2016.
Mani worked as a strategic management consultant and has advised Provider organizations, Biotech and Medical devices firms. Currently serves on the board of HD medical group and Strategic advisor to Guardant Health.
Earlier he worked for Johnson and Johnson Medical devices where he was responsible for technology and portfolio management.
Mani started his career as a Cardiologist at the Apollo hospitals group in Chennai where he was trained in intervention cardiology. He was one of the pioneers in conducting multinational clinical trials as an investigator for Eli Lilly, Servier and Covance.
Mani Holds a MD degree from Prestigious Madras Medical college where he graduated among the
top 5% of the class, Fellowship in Cardiology and an MBA ( Finance & Strategy)from the Wharton School of The University of Pennsylvania.